- Home
- SPXC vs BBIO Comparison
SPXC vs BBIO Comparison
Compare SPXC & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPXC
- BBIO
- Stock Information
- Founded
- SPXC 1912
- BBIO 2015
- Country
- SPXC United States
- BBIO United States
- Employees
- SPXC 4300
- BBIO N/A
- Industry
- SPXC Industrial Machinery/Components
- BBIO Biotechnology: Pharmaceutical Preparations
- Sector
- SPXC Industrials
- BBIO Health Care
- Exchange
- SPXC Nasdaq
- BBIO Nasdaq
- Market Cap
- SPXC 9.2B
- BBIO 9.4B
- IPO Year
- SPXC N/A
- BBIO 2019
- Fundamental
- Price
- SPXC $187.00
- BBIO $51.89
- Analyst Decision
- SPXC Strong Buy
- BBIO Strong Buy
- Analyst Count
- SPXC 4
- BBIO 16
- Target Price
- SPXC $200.25
- BBIO $64.44
- AVG Volume (30 Days)
- SPXC 256.2K
- BBIO 2.2M
- Earning Date
- SPXC 10-29-2025
- BBIO 11-11-2025
- Dividend Yield
- SPXC N/A
- BBIO N/A
- EPS Growth
- SPXC 100.86
- BBIO N/A
- EPS
- SPXC 4.47
- BBIO N/A
- Revenue
- SPXC $2,052,400,000.00
- BBIO $235,812,000.00
- Revenue This Year
- SPXC $15.43
- BBIO $115.97
- Revenue Next Year
- SPXC $8.03
- BBIO $65.50
- P/E Ratio
- SPXC $41.54
- BBIO N/A
- Revenue Growth
- SPXC 8.90
- BBIO 7.62
- 52 Week Low
- SPXC $115.00
- BBIO $21.72
- 52 Week High
- SPXC $209.38
- BBIO $54.60
- Technical
- Relative Strength Index (RSI)
- SPXC 49.03
- BBIO 53.91
- Support Level
- SPXC $184.27
- BBIO $52.20
- Resistance Level
- SPXC $191.95
- BBIO $54.29
- Average True Range (ATR)
- SPXC 3.50
- BBIO 1.89
- MACD
- SPXC -0.48
- BBIO -3.00
- Stochastic Oscillator
- SPXC 44.68
- BBIO 95.05
About SPXC SPX Technologies Inc.
SPX Technologies Inc supplies engineered heating, ventilation, and air conditioning, or HVAC, products, as well as detection and measurement technologies and power equipment. The company through two reportable segments. The HVAC segment which generates the majority of the revenue for the company, designs, manufactures, installs, and services cooling products, as well as heating and ventilation products. The detection and measurement technologies segment designs, manufactures, and installs underground pipe and cable locators and inspection equipment, bus-fare collection systems, and others. Geographically, the company has its operations in the United States, Canada, China, the United Kingdom, and Others.
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.